Search Results - Erälinna, J.P.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with a suboptimal response to previous disease-modifying therapies (1‑year interim results)

    Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with a suboptimal response to previous disease-modifying therapies (1‑year interim result... by Vermersch, P., Eralinna, J.P., Nicholas, R., Oreja-Guevara, C., Siva, A., Van Wijmeersch, B., Wiendl, H., Buffels, R., Kuhelj, R., Wei, W., Comi, G.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Blood-brain barrier breakdown and increased intercellular adhesion molecule (ICAM-1/CD54) expression after Semliki Forest ( A7) virus infection facilitates the development of experimental allergic encephalomyelitis

    Blood-brain barrier breakdown and increased intercellular adhesion molecule (ICAM-1/CD54) expression after Semliki Forest ( A7) virus infection facilitates the development of exper... by Erälinna, J.P., Soilu-hänninen, M., Röyttä, M., Hukkanen, V., Salmi, A.A., Salonen, R.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: